Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA

Oligonucleotides

Volumn 20, Issue 3, 2010, Pages 163-172

  Ghosn, Bilal ^a   Singh, Ankur ^a   Li, Mu ^b   Vlassov, Alexander V ^b   Burnett, Chris ^b   Puri, Nitin ^b   Roy, Krishnendu ^a  

^a The University of Texas at Austin   (United States)

^b Life Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 IMIDAZOLEACETIC ACID; APOLIPOPROTEIN B; CHITOSAN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); MACROGOL; NANOCARRIER; SMALL INTERFERING RNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENE SILENCING; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; GENETICS; METABOLISM;

ANIMALS; CHITOSAN; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; LIVER; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, SMALL INTERFERING;

EID: 77954120438     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2010.0235     Document Type: Article

References (42)

1. AMARZGUIOUI, M., HOLEN, T., BABAIE, E., and PRYDZ, H. (2003). Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31, 589-595.
2. BERNKOP-SCHNURCH, A., GUGGI, D., and PINTER, Y. (2004). Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Release. 94, 177-186. (Pubitemid 37542387)
3. BITKO, V., MUSIYENKO, A., SHULYAYEVA, O., and BARIK, S. (2005). Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50-55.
4. CASTANOTTO, D., and ROSSI, J.J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature. 457, 426-433.
5. DALLAS, A., and VLASSOV, A.V. (2006). RNAi: a novel anti-sense technology and its therapeutic potential. Med. Sci. Monit. 12, RA67-RA74.
6. DE MARTIMPREY, H., BERTRAND, J.R., FUSCO, A., SAN-TORO, M., COUVREUR, P., VAUTHIER, C., and MALVY, C. (2008). siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res. 36, e2.
7. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411, 494-498.
8. ELMEN, J., THONBERG, H., LJUNGBERG, K., FRIEDEN, M., WESTERGAARD, M., XU, Y., WAHREN, B., LIANG, Z., ORUM, H., KOCH, T., and WAHLESTEDT, C. (2005). Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439-447.
9. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
10. FLOREA, B.I., THANOU, M., JUNGINGER, H.E., and BORCHARD, G. (2006). Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J. Control. Release. 110, 353-361.
11. GAO, S., CHEN, J., DONG, L., DING, Z., YANG, Y.H., and ZHANG, J. (2005). Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. Eur. J. Pharm. Biopharm. 60, 327-334.
12. GHOSN, B., KASTURI, S., and ROY, K. (2008). Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines. Curr. Top. Med. Chem. 8, 331-340.
13. HANSON, K.A., BURNS, F., RYBALKIN, S.D., MILLER, J.W., BEAVO, J., and CLARKE, W.R. (1998). Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. Am. J. Respir. Crit. Care Med. 158, 279-288.
14. HICKERSON, R.P., VLASSOV, A.V., WANG, Q., LEAKE, D., ILVES, H., GONZALEZ-GONZALEZ, E., CONTAG, C.H., JOHNSTON, B.H., and KASPAR, R.L. (2008). Stability study of unmodified siRNA and relevance to clinical use. Oligonu-cleotides. 18, 345-354.
15. HOWARD, K.A., RAHBEK, U.L., LIU, X., DAMGAARD, C.K., GLUD, S.Z., ANDERSEN, M.O., HOVGAARD, M.B., SCHMITZ, A., NYENGAARD, J.R., BESENBACHER, F., and KJEMS, J. (2006). RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 14, 476-484.
16. JIANG, H.L., KIM, Y.K., AROTE, R., NAH, J.W., CHO, M.H., CHOI, Y.J., AKAIKE, T., and CHO, C.S. (2007). Chitosan-graft-polyethylenimine as a gene carrier. J. Control. Release. 117, 273-280.
17. KATAS, H., and ALPAR, H.O. (2006). Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release. 115, 216-225.
18. KHAN, A., BENBOUBETRA, M., SAYYED, P.Z., NG, K.W., FOX, S., BECK, G., BENTER, I.F., and AKHTAR, S. (2004). Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J. Drug. Target. 12, 393-404.
19. KOSHKIN, A.A., SINGH, S.K., NIELSEN, P., RAJWANSHI, V.K., KUMAR, R., MELDGAARD, M., OLSEN, C.E., and WENGEL, J. (1998). LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron. 54, 3607-3630.
20. LEWIS, D.L., HAGSTROM, J.E., LOOMIS, A.G., WOLFF, J.A., and HERWEIJER, H. (2002). Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32, 107-108.
21. LEWIS, D.L., and WOLFF, J.A. (2005). Delivery of siRNA and siRNA expression constructs to adult mammals by hydrody-namic intravascular injection. Methods Enzymol. 392, 336-350.
22. LIAO, H., and WANG, J.H. (2005). Biomembrane-permeable and ribonuclease-resistant siRNA with enhanced activity. Oligonucleotides. 15, 196-205.
23. LIVAK, K.J., and SCHMITTGEN, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
24. MAO, H.Q., ROY, K., TROUNG-LE, V.L., JANES, K.A., LIN, K.Y., WANG, Y., AUGUST, J.T., and LEONG, K.W. (2001). Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release. 70, 399-421.
25. MASSARO, D., MASSARO, G.D., and CLERCH, L.B. (2004). Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L1066-L1070.
26. MCCAFFREY, A.P., MEUSE, L., PHAM, T.T., CONKLIN, D.S., HANNON, G.J., and KAY, M.A. (2002). RNA interference in adult mice. Nature. 418, 38-39.
27. MORRISSEY, D.V., LOCKRIDGE, J.A., SHAW, L., BLAN-CHARD, K., JENSEN, K., BREEN, W., HARTSOUGH, K., MACHEMER, L., RADKA, S., JADHAV, V., VAISH, N., ZINNEN, S., VARGEESE, C., BOWMAN, K., SHAFFER, C.S., JEFFS, L.B., JUDGE, A., MACLACHLAN, I., and POLISKY, B. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002-1007.
28. MOSCHOS, S.A., JONES, S.W., PERRY, M.M., WILLIAMS, A.E., ERJEFALT, J.S., TURNER, J.J., BARNES, P.J., SPROAT, B.S., GAIT, M.J., and LINDSAY, M.A. (2007). Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem. 18, 1450-1459.
29. NING, S., FUESSEL, S., KOTZSCH, M., KRAEMER, K., KAP-PLER, M., SCHMIDT, U., TAUBERT, H., WIRTH, M.P., and MEYE, A. (2004). siRNA-mediated down-regulation of survi-vin inhibits bladder cancer cell growth. Int. J. Oncol. 25, 1065-1071.
30. PACK, D.W., PUTNAM, D., and LANGER, R. (2000). Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol. Bioeng. 67, 217-223.
31. PARK, I.K., KIM, T.H., PARK, Y.H., SHIN, B.A., CHOI, E.S., CHOWDHURY, E.H., AKAIKE, T., and CHO, C.S. (2001). Galactosylated chitosan-graft- poly(ethylene glycol) as hepatocyte-targeting DNA carrier. J. Control. Release. 76, 349-362.
32. PILLE, J., LI, H., BLOT, E., BERTRAND, J., PRITCHARD, L., OPOLON, P., MAKSIMENKO, A., LU, H., VANNIER, J., SORIA, J., MALVY, C., and SORIA, C. (2006). Intravenous delivery of anti-RhoA small interfering RNA loaded in nano-particles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 17, 1019-1026.
33. RAMON, A.L., BERTRAND, J.R., and MALVY, C. (2008). Delivery of small interfering RNA. A review and an example of application to a junction oncogene. Tumori. 94, 254-263.
34. ROSETTE, C., ROTH, R.B., OETH, P., BRAUN, A., KAM-MERER, S., EKBLOM, J., and DENISSENKO, M.F. (2005). Role of ICAM1 in invasion of human breast cancer cells. Carcino-genesis 26, 943-950.
35. ROY, K., MAO, H.Q., HUANG, S.K., and LEONG, K.W. (1999). Oral gene delivery with chitosan\DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5, 387-391.
36. ROY, K., WANG, D., HEDLEY, M.L., and BARMAN, S.P. (2003). Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression. Mol. Ther. 7, 401-408.
37. SCHIFFELERS, R.M., XU, J., STORM, G., WOODLE, M.C., and SCARIA, P.V. (2005). Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum. 52, 1314-1318.
38. SINGH, A., NIE, H., GHOSN, B., QIN, H., KWAK, L.W., and ROY, K. (2008). Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells. Mol. Ther. 16, 2011-2021.
39. SOGIAS, I.A., WILLIAMS, A.C., and KHUTORYANSKIY, V.V. (2008). Why is chitosan mucoadhesive? Biomacromolecules. 9, 1837-1842.
40. SOUTSCHEK, J., AKINC, A., BRAMLAGE, B., CHARISSE, K., CONSTIEN, R., DONOGHUE, M., ELBASHIR, S., GEICK, A., HADWIGER, P., HARBORTH, J., JOHN, M., KESAVAN, V., LAVINE, G., PANDEY, R.K., RACIE, T., RAJEEV, K.G., ROHL, I., TOUDJARSKA, I., WANG, G., WUSCHKO, S., BUMCROT, D., KOTELIANSKY, V., LIMMER, S., MANO-HARAN, M., and VORNLOCHER, H.P. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 432, 173-178.
41. YIN, J.Q., GAO, J., SHAO, R., TIAN, W.N., WANG, J., and WAN, Y. (2003). siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J. Exp. Ther. Oncol. 3, 194-204.
42. ZIMMERMANN, T.S., LEE, A.C., AKINC, A., BRAMLAGE, B., BUMCROT, D., FEDORUK, M.N., HARBORTH, J., HEYES, J.A., JEFFS, L.B., JOHN, M., JUDGE, A.D., LAM, K., MCCLINTOCK, K., NECHEV, L.V., PALMER, L.R., RACIE, T., ROHL, I., SEIFFERT, S., SHANMUGAM, S., SOOD, V., SOUTSCHEK, J., TOUDJARSKA, I., WHEAT, A.J., YA-WORSKI, E., ZEDALIS, W., KOTELIANSKY, V., MANO-HARAN, M., VORNLOCHER, H.P., and MACLACHLAN, I. (2006). RNAi-mediated gene silencing in non-human primates. Nature. 441, 111-114.